The critique discusses fifty eight peptides in various clinical phases, indicating a robust pipeline of peptide therapies focusing on PPIs. A lot more than 200 ncAAs with numerous functionalities have already been genetically encoded into different organisms so far, for example Escherichia coli Many other authorized peptide medication will al